European Archives - Page 317 of 1588 - European Medical Journal

EMJ Dermatology 13.1 2025

We are delighted to announce the release of our latest EMJ Dermatology issue! Inside, you will find a diverse array of content, including…

EMJ's latest diabetes journal

Covering all the latest from EASD 2025 and beyond, our new instalment has everything you need to know in the diabetes space. Inside…

Review of the European Association for the Study of Diabetes (EASD) Annual Meeting 2025

PHYSICAL activity is a well-established component of managing Type 2 diabetes (T2D), with benefits including improved…

Physical Function Outcomes in People with Type 2 Diabetes

Physical function decline is an increasingly recognised concern among individuals with long-term conditions such as Type 2 diabetes (T2D)…

Classification of Patients with Dermal Leiomyosarcoma

Cutaneous leiomyosarcoma is a rare smooth muscle neoplasm that can be classified as dermal or subcutaneous depending on the depth of…

Islet Replacement, Tolerance Induction, and the Path Beyond Immunosuppression in Type 1 Diabetes

THE THERAPEUTIC landscape for Type 1 diabetes (T1D) is undergoing a paradigm shift, transitioning from lifelong…

Lasers as Epigenetic Modulators: EADV 2025

LASERS have transformed dermatology by offering effective treatments for photo-ageing, scars, and pigmentary disorders. Traditionally…

Viral Triggers of Autoimmune Diabetes

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from the destruction of insulin-producing β-cells in the pancreas…

Ruxolitinib Cream in Vitiligo Management: Real World Experience

Zink opened the session by recapping key efficacy data for ruxolitinib cream in non-segmental vitiligo from the TRuE-V1/2 registration…

Uncontrolled Diabetes Presenting as Eruptive Xanthoma

Eruptive xanthoma is considered a rare disease with an incidence of 18 out of 100,000. It can only be seen in 10% of patients with…